Children with atopic dermatitis (AD) were more likely to have a diagnosed sleep disturbance than children without the condition, and the association did not differ significantly by atopy or mental health status, according to a retrospective analysis presented at the 2026 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
AD, also known as eczema, causes dry, itchy, inflamed skin and is among the most common skin conditions in children. Allergists have long recognized that it can disrupt sleep, but most earlier research looked at small groups of children, often from specialty clinics. Diverse pediatric populations have also been underrepresented in prior studies. How comorbid atopy and mental health conditions affect the AD-sleep relationship in underserved children has remained unclear.
Methodology
Samantha Sundermeier, DO, an attending physician at Children's Hospital of Philadelphia, and a coauthor reviewed electronic health records for 26,395 patients, from birth to age 21, seen at a primary care clinic from January 2024 to January 2026.
The researchers searched the records for diagnoses of AD, sleep disturbance, atopy and mental health conditions. They assessed the link between AD and sleep disturbance with contingency tables, odds ratios (ORs) with 95% confidence intervals (CIs) and chi-square tests. They then stratified patients by atopy and by mental health comorbidity and compared the subgroup estimates to test for effect modification.
Key Findings
AD was present in 14.5% of patients, sleep disturbance in 10.3%, atopy in 34.9% and mental health conditions in 11.5%. The occurrence of both AD and sleep disturbance was recorded in 1.8% of all patients. According to the news release, about 12% of children with AD had a sleep problem, compared with about 10% of children without AD.
AD was associated with increased odds of sleep disturbance (OR 1.28; 95% CI, 1.15-1.42; chi-square = 20.91; P<0.001). The association was similar across subgroups, with subgroup estimates of OR 1.17 (95% CI, 0.90-1.52) in patients with a mental health condition, OR 1.30 (95% CI, 1.16-1.46) in those without a mental health condition, OR 1.08 (95% CI, 0.94-1.25) in patients with atopy, and OR 1.28 (95% CI, 1.09-1.51) for those without atopy.
The confidence intervals for the subgroups with a mental health condition (0.90–1.52) or with atopy (0.94–1.25) included 1.0, although the tests for effect modification were not significant (P=0.46 for mental health, P=0.12 for atopy), and the authors concluded the association was consistent across subgroups.
Tests for effect modification were not significant for mental health (P=0.46) or atopy (P=0.12). The confidence intervals for the subgroups with a mental health condition or with atopy included 1.0.
“Eczema is often thought of as just a skin problem, but our findings suggest it is associated with a child's overall well-being, particularly their sleep,” Sundermeier said in the news release.
“We found that children with eczema were more likely to have a diagnosed sleep disturbance, and the relationship was similar whether they also had a mental health condition or other allergic conditions,” she said in the release. “This highlights the importance of asking about sleep, not just skin symptoms, when caring for children with eczema.”
Limitations
This was a retrospective review of diagnoses recorded in electronic health records; the findings indicate an association and not causation. The abstract did not report AD severity, how sleep disturbance was defined or measured, or what treatments the children received.



